Peritubular capillary loss is ameliorated by ramipril or valsartan treatment

Microcirculation

Volumn 15, Issue 4, 2008, Pages 337-348

  Zhang, Bin ^a   Chen, Nan ^b   Shi, Wei ^a   Wang, Weiming ^b   Shi, Hao ^b   Yu, Haijin ^b  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Eritubular capillary; Hypoxia; Nephrectomy; Ramipril; Renin angiotensin system; Valsartan

Indexed keywords

AMLODIPINE; ANTIGEN; CD141 ANTIGEN; CREATININE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RAMIPRIL; TRANSFORMING GROWTH FACTOR BETA; VALSARTAN; MONOCLONAL ANTIBODY; THROMBOMODULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAPILLARY FLOW; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; HYPOXIA; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RENAL PROTECTION; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINE VOLUME; ANIMAL CELL; CAPILLARY DENSITY; GLOMERULUS CAPILLARY; HYPOXEMIA; KIDNEY CIRCULATION; KIDNEY INTERSTITIUM; MUELLERIAN DUCT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; ANOXIA; ANTIHYPERTENSIVE AGENTS; CAPILLARIES; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY TUBULES; MALE; MICROCIRCULATION; RAMIPRIL; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES; TRANSFORMING GROWTH FACTOR BETA; VALINE;

RATTUS;

EID: 46149117256     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680701743540     Document Type: Article

References (32)

1. Wolf, G., Butzmann, U. and Wenzel, U. O. (2003) The renin-angiotensin system and progression of renal disease: From hemodynamics to cell biology. Nephron Physiol, 93, pp. p3-p13.
2. Jafar, T. H., Stark, P. C., Schmid, C. H., Landa, M., Maschio, G., de Jong, P. E., de Zeeuw, D., Shahinfar, S., Toto, R., Levey, A. S. and AIPRD Study Group (2003) Progression of chronic kidney disease: The role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: A patient-level meta-analysis. Ann Intern Med, 139, pp. 244-252.
3. Atkins, R. C., Briganti, E. M., Lewis, J. B., Hunsicker, L. G., Braden, G., Champion de Crespigny, P J, DeFerrari, G., Drury, P., Locatelli, F., Wiegmann, T. B. and Lewis, E. J. (2005) Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis, 45, pp. 281-287.
4. Nangaku, M. (2006) Chronic hypoxia and tubulointerstitial injury: A final common pathway to end-stage renal failure. J Am Soc Nephrol, 17, pp. 17-25.
5. Manotham, K., Tanaka, T., Matsumoto, M., Ohse, T., Miyata, T., Inagi, R., Kurokawa, K., Fujita, T. and Nangaku, M. (2004) Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol, 15, pp. 1277-1288.
6. Norman, J. T., Stidwill, R., Singer, M. and Fine, L. G. (2003) Angiotensin II blockade augments renal cortical microvascular pO2 indicating a novel, potentially renoprotective action. Nephron Physiol, 94, pp. p39-p46.
7. Lombardi, D., Gordon, K. L., Polinsky, P., Suga, S., Schwartz, S. M. and Johnson, R. J. (1999) Salt-sensitive hypertension develops after short-term exposure to Angiotensin II. Hypertension, 33, pp. 1013-1019.
8. Shao, J., Nangaku, M., Miyata, T., Inagi, R., Yamada, K., Kurokawa, K. and Fujita, T. (2003) Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension, 42, pp. 31-38.
9. Ibrahim, H. N. and Hostetter, T. (1998) The renin-aldosterone axis in two models of reduced renal mass in the rat. J Am Soc Nephrol, 9, pp. 72-76.
10. Shimizu, A., Kitamura, H., Masuda, Y., Ishizaki, M., Sugisaki, Y. and Yamanaka, N. (1997) Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am J Pathol, 151, pp. 1231-1239.
11. Ohashi, R., Kitamura, H. and Yamanaka, N. (2000) Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol, 11, pp. 47-56.
12. Kim, Y. G., Suga, S., Kang, D. H., Jefferson, J. A., Mazzali, M., Gordon, K. L., Matsui, K., Breiteneder-Geleff, S., Shankland, S. J., Hughes, J., Kerjaschki, D., Schreiner, G. F. and Johnson, R. J. (2000) Vascular endothelial growth factor stimulates vascular remodeling and tissue repair in a model of thrombotic microangiopathy. Kidney Int, 58, pp. 2390-2399.
13. Kang, D. H., Joly, A. H., Oh, S. W., Hugo, C., Kerjaschki, D., Gordon, K. L., Mazzali, M., Jefferson, J. A., Hughes, J., Madsen, K. M., Schreiner, G. F. and Johnson, R. J. (2001) Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol, 12, pp. 1434-1447.
14. Bohle, A., von Gise, H., Mackensen-Haen, S. and Stark-Jakob, B. (1981) The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Functional interpretation of morphologic findings. Klin Wochenschr, 59, pp. 1043-1051.
15. Choi, Y. J., Chakraborty, S., Nguyen, V., Nguyen, C., Kim, B. K., Shim, S. I., Suki, W. N. and Truong, L. D. (2000) Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor. Hum Pathol, 31, p. 1491.
16. Yuan, H-T, Li, X-Z, Pitera, J. E., Long, D. A. and Woolf, A. S. (2003) Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1alpha. Am J Pathol, 163, p. 2289.
17. Kairaitis, L. K., Wang, Y., Gassmann, M., Tay, Y. C. and Harris, D. C. (2005) HIF-1alpha expression follows microvascular loss in advanced murine adriamycin nephrosis. Am J Physiol Renal Physiol, 288, pp. F198-F20.
18. Colman, R. W. (2006) Regulation of angiogenesis by the kallikrein-kinin system. Curr Pharm Des, 12, p. 2599.
19. Agodoa, L. Y., Appel, L., Bakris, G. L., Beck, G., Bourgoignie, J., Briggs, J. P., Charleston, J., Cheek, D., Cleveland, W., Douglas, J. G., Douglas, M., Dowie, D., Faulkner, M., Gabriel, A., Gassman, J., Greene, T., Hall, Y., Hebert, L., Hiremath, L., Jamerson, K., Johnson, C. J., Kopple, J., Kusek, J., Lash, J., Lea, J., Lewis, J. B., Lipkowitz, M., Massry, S., Middleton, J., Miller 3rd, E. R., Norris, K., O'Connor, D., Ojo, A., Phillips, R. A., Pogue, V., Rahman, M., Randall, O. S., Rostand, S., Schulman, G., Smith, W., Thornley-Brown, D., Tisher, C. C., Toto, R. D., Wright Jr, J. T., Xu, S. and African American Study of Kidney Disease and Hypertension (AASK) Study Group (2001) Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial. JAMA, 285, pp. 2719-2728.
20. Wright Jr., J. T., Bakris, G., Greene, T., Agodoa, L. Y., Appel, L. J., Charleston, J., Cheek, D., Douglas-Baltimore, J. G., Gassman, J., Glassock, R., Hebert, L., Jamerson, K., Lewis, J., Phillips, R. A., Toto, R. D., Middleton, J. P., Rostand, S. G. and African Am Study of Kidney Disease and Hypertension Study Group (2002) Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA, 288, pp. 2421-2431.
21. Ruggenenti, P., Perna, A., Benini, R., Remuzzi, G. and for the "gruppo italiano di studi epidemiologici in nefrologia" (GISEN) (1998) Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. J Am Soc Nephrol, 9, pp. 2096-2101.
22. Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H. H., Remuzzi, G., Snapinn, S. M., Zhang, Z., Shahinfar, S. and RENAAL Study Investigators (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med, 345, pp. 861-869.
23. Safran, M. and Kaelin, W. G. (2003) HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest, 111, p. 779.
24. Rosenberger, C., Mandriota, S., Jurgensen, J. S., Wiesener, M. S., Horstrup, J. H., Frei, U., Ratcliffe, P. J., Maxwell, P. H., Bachmann, S. and Eckardt, K. U. (2002) Expression of hypoxia-inducible factor-1alpha and-2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol, 13, pp. 1721-1732.
25. Griffin, K. A., Picken, M. M., Churchill, M., Churchill, P. and Bidani, A. K. (2000) Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol, 11, pp. 497-506.
26. Fine, L. G., Bandyopadhay, D. and Norman, J. T. (2000) Is there a common mechanism for the progression of different types of renal disease other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int, 57, pp. S22-S26.
27. Norman, J. T., Clark, I. M. and Garcia, P. (2000) Hypoxia promotes fibrogenesis in human renal fibroblast. Kidney Int, 58, pp. 2351-2366.
28. Orphanides, C., Fine, L. G. and Norman, J. T. (1997) Hypoxia stimulates proximal tubular cell matrix production via TGF-β1 independent mechanism. Kidney Int, 52, pp. 637-647.
29. Tanaka, T., Hanafusa, N., Ingelfinger, J. R., Ohse, T., Fujita, T. and Nangaku, M. (2003) Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. Biochem Biophys Res Commun, 309, pp. 222-231.
30. Tanaka, T., Miyata, T., Inagi, R., Kurokawa, K., Adler, S., Fujita, T. and Nangaku, M. (2003) Hypoxia-induced apoptosis in cultured glomerular endothelial cells: Involvement of mitochondrial pathways. Kidney Int, 64, pp. 2020-2032.
31. Manotham, K., Tanaka, T., Matsumoto, M., Ohse, T., Inagi, R., Miyata, T., Kurokawa, K., Fujita, T., Ingelfinger, J. R. and Nangaku, M. (2004) Transdifferentiation of cultured tubular cell induced by hypoxia. Kidney Int, 65, pp. 871-880.
32. Loutzenhiser, R. D., Epstein, M., Fischetti, F. and Horton, C. (1989) Effects of amlodipine on renal hemodynamics. Am J Cardiol, 64, pp. 122I-127I.